Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Asset Writedowns and Impairment (2018 - 2025)

Bio-Techne has reported Asset Writedowns and Impairment over the past 5 years, most recently at $84.2 million for Q2 2025.

  • For Q2 2025, Asset Writedowns and Impairment rose 428.46% year-over-year to $84.2 million; the TTM value through Jun 2025 reached $96.4 million, up 505.51%, while the annual FY2025 figure was $80.5 million, 266.54% up from the prior year.
  • Asset Writedowns and Impairment for Q2 2025 was $84.2 million at Bio-Techne, up from -$3.7 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $84.2 million in Q2 2025 and troughed at -$3.7 million in Q1 2025.
  • A 3-year average of $23.1 million and a median of $15.9 million in 2024 define the central range for Asset Writedowns and Impairment.
  • On a YoY basis, Asset Writedowns and Impairment climbed as much as 428.46% in 2025 and fell as far as 428.46% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at $18.7 million in 2021, then dropped by 14.91% to $15.9 million in 2024, then surged by 428.46% to $84.2 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for TECH at $84.2 million in Q2 2025, -$3.7 million in Q1 2025, and $15.9 million in Q2 2024.